FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088896689> ?p ?o ?g. }

• W2088896689 endingPage "5575" @default.
• W2088896689 startingPage "5567" @default.
• W2088896689 abstract "Previous studies have shown that in vivo treatment with antiinterferon-gamma (anti-IFNgamma) monoclonal antibodies (mAbs) prevents the development of autoimmune diabetes in NOD mice. Although these findings anticipate that specific anti-IFNgamma therapies may be useful for the prevention/treatment of human insulin-dependent diabetes mellitus, there are several reasons why the use of anti-IFNgamma mAb may be difficult in the clinical setting. With the aim to develop alternative forms of specific anti-IFNgamma therapies, we recently produced a nonimmunogenic form of the soluble IFNgamma receptor (sIFNgammaR) that binds and neutralizes murine IFNgamma with an affinity higher than that of anti-IFNgamma mAb. In this study we compared the efficacy of sIFNgammaR to that of two anti-IFNgamma mAbs (XMG 1.2 and AN-18) in the prevention of spontaneous and accelerated (cyclophosphamide-induced) forms of autoimmune diabetes in NOD mice. The results show that in the spontaneous model, sIFNgammaR could prevent histological and clinical signs of autoimmune diabetes as efficiently as the two mAbs. Under ex vivo conditions, sIFNgammaR exhibited a more powerful modulatory effect than XMG 1.2 mAb on cytokine secretion from splenic lymphoid cells, which resulted in a significant reduction of Concanavalin A-induced IL-2 secretion and an augmented release of both unstimulated and lipopolysaccharide-induced IL-6. Moreover, although both mAbs were immunogenic and elicited formation of high titers of anti-rat IgG, sIFNgammaR did not induce antibody formation. Unexpectedly, in the cyclophosphamide-induced model, sIFNgammaR turned out to be less effective than either of the two anti-IFNgamma mAbs. Taken together, these data support the role of IFNgamma in the pathogenesis of NOD mice, but, more importantly, suggest that a nonimmunogenic approach is possible to the diminution of the effects of IFNgamma in this model." @default.
• W2088896689 created "2016-06-24" @default.
• W2088896689 creator A5010062544 @default.
• W2088896689 creator A5011608463 @default.
• W2088896689 creator A5025654850 @default.
• W2088896689 creator A5028577533 @default.
• W2088896689 creator A5035780912 @default.
• W2088896689 creator A5051900722 @default.
• W2088896689 creator A5056105834 @default.
• W2088896689 creator A5059940755 @default.
• W2088896689 creator A5088300868 @default.
• W2088896689 date "1996-12-01" @default.
• W2088896689 modified "2023-10-16" @default.
• W2088896689 title "The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in the NOD mouse." @default.
• W2088896689 cites W1510755693 @default.
• W2088896689 cites W1528765374 @default.
• W2088896689 cites W1626943053 @default.
• W2088896689 cites W1932588934 @default.
• W2088896689 cites W1969588461 @default.
• W2088896689 cites W1974599629 @default.
• W2088896689 cites W1994604086 @default.
• W2088896689 cites W1998052632 @default.
• W2088896689 cites W2005246059 @default.
• W2088896689 cites W2009531856 @default.
• W2088896689 cites W2012385634 @default.
• W2088896689 cites W2020250668 @default.
• W2088896689 cites W2022368079 @default.
• W2088896689 cites W2035756597 @default.
• W2088896689 cites W2041469322 @default.
• W2088896689 cites W2044585677 @default.
• W2088896689 cites W2051375451 @default.
• W2088896689 cites W2076973702 @default.
• W2088896689 cites W2081041392 @default.
• W2088896689 cites W2084322883 @default.
• W2088896689 cites W2085050817 @default.
• W2088896689 cites W2087034628 @default.
• W2088896689 cites W2097885269 @default.
• W2088896689 cites W2102524411 @default.
• W2088896689 cites W2126323534 @default.
• W2088896689 cites W2142913183 @default.
• W2088896689 cites W2147863023 @default.
• W2088896689 cites W2157501159 @default.
• W2088896689 cites W2164924638 @default.
• W2088896689 cites W2412877632 @default.
• W2088896689 cites W95884546 @default.
• W2088896689 doi "https://doi.org/10.1210/endo.137.12.8940385" @default.
• W2088896689 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8940385" @default.
• W2088896689 hasPublicationYear "1996" @default.
• W2088896689 type Work @default.
• W2088896689 sameAs 2088896689 @default.
• W2088896689 citedByCount "55" @default.
• W2088896689 countsByYear W20888966892012 @default.
• W2088896689 countsByYear W20888966892013 @default.
• W2088896689 countsByYear W20888966892014 @default.
• W2088896689 countsByYear W20888966892015 @default.
• W2088896689 countsByYear W20888966892016 @default.
• W2088896689 countsByYear W20888966892017 @default.
• W2088896689 countsByYear W20888966892018 @default.
• W2088896689 countsByYear W20888966892019 @default.
• W2088896689 countsByYear W20888966892021 @default.
• W2088896689 countsByYear W20888966892022 @default.
• W2088896689 crossrefType "journal-article" @default.
• W2088896689 hasAuthorship W2088896689A5010062544 @default.
• W2088896689 hasAuthorship W2088896689A5011608463 @default.
• W2088896689 hasAuthorship W2088896689A5025654850 @default.
• W2088896689 hasAuthorship W2088896689A5028577533 @default.
• W2088896689 hasAuthorship W2088896689A5035780912 @default.
• W2088896689 hasAuthorship W2088896689A5051900722 @default.
• W2088896689 hasAuthorship W2088896689A5056105834 @default.
• W2088896689 hasAuthorship W2088896689A5059940755 @default.
• W2088896689 hasAuthorship W2088896689A5088300868 @default.
• W2088896689 hasBestOaLocation W20888966891 @default.
• W2088896689 hasConcept C126322002 @default.
• W2088896689 hasConcept C134018914 @default.
• W2088896689 hasConcept C150903083 @default.
• W2088896689 hasConcept C159654299 @default.
• W2088896689 hasConcept C203014093 @default.
• W2088896689 hasConcept C207001950 @default.
• W2088896689 hasConcept C2776694085 @default.
• W2088896689 hasConcept C2776755627 @default.
• W2088896689 hasConcept C2778013207 @default.
• W2088896689 hasConcept C2778690821 @default.
• W2088896689 hasConcept C2779075594 @default.
• W2088896689 hasConcept C2780841837 @default.
• W2088896689 hasConcept C542903549 @default.
• W2088896689 hasConcept C555293320 @default.
• W2088896689 hasConcept C55851684 @default.
• W2088896689 hasConcept C71924100 @default.
• W2088896689 hasConcept C86803240 @default.
• W2088896689 hasConceptScore W2088896689C126322002 @default.
• W2088896689 hasConceptScore W2088896689C134018914 @default.
• W2088896689 hasConceptScore W2088896689C150903083 @default.
• W2088896689 hasConceptScore W2088896689C159654299 @default.
• W2088896689 hasConceptScore W2088896689C203014093 @default.
• W2088896689 hasConceptScore W2088896689C207001950 @default.
• W2088896689 hasConceptScore W2088896689C2776694085 @default.
• W2088896689 hasConceptScore W2088896689C2776755627 @default.
• W2088896689 hasConceptScore W2088896689C2778013207 @default.

• next